Access Official Technical PDF

Share Summary:LinkedInEmail

Roll-to-roll manufacturing can bring several fabrication and assembly steps together on a continuous polymer web, offering a route to higher-volume production of disposable diagnostic devices. A pilot-line demonstration of an integrated immunodetection sensor shows how hot embossing, reagent dispensing, solvent lamination and component placement can be coordinated to make a working microfluidic device. For industrial automation teams, the work illustrates both the promise of process integration and the importance of controlling interactions between materials, web handling and assay performance.

Why integrate microfluidic device manufacturing?

Point-of-care tests are intended for use at or near the site of care. Their compact format can conceal a sequence of laboratory operations: preparing a sample, moving small liquid volumes, mixing reagents and detecting a target. Microfluidics helps miniaturize these operations, but commercial implementation has faced challenges including manufacturing cost and the difficulty of integrating separate functions into a dependable device.

Roll-to-roll (R2R) processing handles a continuous flexible substrate, or web, using successive additive and subtractive operations. It is already used for products such as films, labels and filters, and can support automated production of functional structures. For a sensor, that opens the possibility of forming channels and adding biological reagents during a connected process rather than assembling every part individually.

The demonstrated device used cyclic olefin copolymer (COC), selected for its optical clarity, thermoplastic properties and compatibility with the assay. Its functions included a plasma-separation membrane, immobilized antibodies, microfluidic channels for sample transport and mixing, and a finger-actuated blister that moved fluid and retained waste.

How the roll-to-roll manufacturing process works

The pilot process linked several operations on a flexible web. First, hot embossing replicated the microfluidic channel pattern in the COC. The channel geometry and its repeatability depended on the combined settings for temperature, pressure and web speed, as well as tension control. These factors cannot be tuned independently: raising temperature can affect web stability, while channel complexity influences how the polymer fills the mold.

After embossing, openings were cut through the web to provide access to the channels. Capture antibodies were then dispensed at the detection area. A blank COC layer was coated with mesitylene using a gravure-printing unit and brought into contact with the channel layer through a nip. The solvent softened the surface sufficiently to bond the layers while preserving open channels. The antibody-containing devices produced a measurable assay response after bonding, although the work did not establish that other antibodies would respond identically to solvent exposure.

A hybrid pick-and-place operation positioned commercial blood-filtration membranes over the channel inlet. This step was the rate-limiting operation in the demonstrated line, with production reaching 60 devices per hour. Blisters were attached manually in this demonstration, though the authors identified that step as one that could also be automated. The example underlines an important production principle: overall line throughput depends on the slowest operation, not only the speed of the primary web process.

Fluid handling without an external pump

The device was designed to move a small whole-blood sample without a bulky external pump. A user pressed the blister to remove air from the channel, applied the sample to the filtration membrane and then released the blister. Its return created negative pressure that drew filtered plasma through the microfluidic path. The blister also served as a waste chamber, keeping the moved liquid contained within the device.

Blister actuation was important because the channel dimensions achievable with the chosen R2R embossing process did not provide the capillary-driven flow needed for the intended operation. The team also designed a meandering section to mix the sample and reagents and increase flow resistance. This illustrates how manufacturing constraints can shape fluidic architecture: a process chosen for scalable fabrication influences channel geometry, which in turn affects how the device must be actuated.

Demonstrating an integrated immunoassay

Performance was demonstrated with a two-site fluorescent immunoassay for C-reactive protein (CRP), a biomarker associated with infection, inflammation and tissue damage. The device incorporated a capture antibody at the detection zone and a fluorescently labelled detection antibody near the inlet. After plasma entered the channel, the label mixed with the sample; CRP was captured at the detection zone, where fluorescence could be read.

The reported test used 20 microlitres of whole blood spiked with 2 micrograms per millilitre of CRP and took approximately 10 minutes. A sample without added CRP served as a check for detectable CRP in the donor blood. The results demonstrated detection under the tested conditions, rather than establishing performance across all samples or clinical settings. Some nonspecific attachment of fluorescent label to the channel was observed, indicating that surface passivation remained an area for further development. Manual blister operation also introduced variation in flow time; a mechanical actuator integrated with a reader could support greater repeatability.

Scale-up considerations for automation teams

The demonstration shows that R2R can integrate more than channel fabrication: it can combine fluidic structures, printed biomolecules, bonded layers and placed components on one flexible substrate. At the same time, process qualification must account for dependencies across the line.

  • Web control: Tension, temperature, pressure and speed influence embossing fidelity and web integrity.
  • Bonding and biology: Solvent lamination must seal the channels without obstructing them or compromising reagent function.
  • Assembly accuracy: Filter placement must align with the fluidic inlet, and component assembly can constrain throughput.
  • System performance: Fluid actuation, mixing, nonspecific binding and assay timing need to be considered together.

In conclusion, roll-to-roll manufacturing offers a practical framework for integrating disposable microfluidic sensors at production scale, but successful scale-up depends on treating fabrication, assembly and assay operation as one coordinated system. The demonstrated CRP sensor provides a concrete example: continuous-web processing formed and assembled key functions, while the remaining manual steps and assay limitations point to the controls and design improvements required for a more repeatable production process.

Access Official Technical PDF

About The Author